Mengqi Liu

Shanghai Cancer Institute, First Affiliated Hospital of Chongqing Medical University

Papers

Total Citations

H-Index

About

Mengqi Liu is a pioneering surgeon-scientist whose work is redefining the boundaries of minimally invasive surgery, particularly in hepatopancreatobiliary and thoracic oncology. Her primary research focuses on expanding the indications for laparoscopic and robotic enucleation of pancreatic tumors, challenging the long-held dogma that tumors involving the main pancreatic duct (MPD) are a contraindication for this organ-sparing approach. In her landmark 2023 study, Liu demonstrated through a robust clinical series from Fudan University that MPD involvement is no longer a restricted area, achieving safe and effective outcomes with robotic and laparoscopic techniques. This work, already garnering 10 citations, has significant implications for preserving pancreatic function and improving patient quality of life. Beyond the pancreas, Liu has advanced the field of pulmonary nodule management. Her 2024 study on robotic-assisted CT-guided percutaneous localization using hook-wire needles addresses a critical challenge in video-assisted thoracoscopic surgery (VATS), offering a more precise and less invasive method for marking small pulmonary nodules. With 5 citations in its first year, this work highlights her commitment to integrating robotics into complex interventional procedures. Liu’s contributions are not merely technical; they represent a paradigm shift toward safer, more patient-centric surgical strategies, establishing her as a rising leader in the era of precision, minimally invasive surgery.